STENTiT is a medical device company that focuses on the development of regenerative endovascular implants.
STENTiT has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
STENTiT's investors include NextGen Ventures, EIT Health, BOM Brabant Ventures, Ten Cate Investeringsmaatschappij.
STENTiT is headquartered in Eindhoven, The Netherlands.
STENTiT is a medical device company that focuses on the development of regenerative endovascular implants.
STENTiT is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"STENTiT — Funding & Investors." VCBacked, April 25, 2022, https://www.vcbacked.co/company/stentit. Accessed September 30, 2026.
VCBacked. (2022). STENTiT — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/stentit
{{cite web |title=STENTiT — Funding & Investors |url=https://www.vcbacked.co/company/stentit |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated